BioNTech evaluates mRNA vaccine manufacturing solutions in Rwanda and Senegal to improve long-term vaccine supply

Berlin: BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) agreed today to evaluate the establishment of sustainable vaccine manufacturing capabilities in Rwanda and Senegal to support vaccine supply for the Member States... Read more »